Champions Oncology (CSBR) Misses Q3 EPS by 10c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.06 +1.40%
Financial Fact:
Provision for income taxes: 14K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Provision for income taxes: 14K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.16), $0.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.5 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Karman Space & Defense acquires Walker Precision Engineering
- Why UBS thinks this European chipmaker is still undervalued despite its premium valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
